Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-2.27 Insider Own27.78% Shs Outstand57.48M Perf Week-4.80%
Market Cap31.34M Forward P/E- EPS next Y-0.72 Insider Trans-0.02% Shs Float41.84M Perf Month-45.90%
Income-131.14M PEG- EPS next Q-0.28 Inst Own21.40% Short Float / Ratio0.71% / 0.98 Perf Quarter-54.92%
Sales1.96M P/S15.99 EPS this Y-2000.00% Inst Trans-4.57% Short Interest0.30M Perf Half Y-45.08%
Book/sh1.52 P/B0.36 EPS next Y61.90% ROA-65.13% Target Price1.50 Perf Year-64.87%
Cash/sh1.78 P/C0.30 EPS next 5Y-9.40% ROE-88.23% 52W Range0.46 - 1.76 Perf YTD-57.06%
Dividend- P/FCF- EPS past 5Y35.83% ROI-114.26% 52W High-69.26% Beta-0.23
Dividend %- Quick Ratio4.22 Sales past 5Y212.04% Gross Margin1.94% 52W Low18.12% ATR0.07
Employees92 Current Ratio4.22 Sales Q/Q-100.00% Oper. Margin-5984.78% RSI (14)21.11 Volatility6.28% 10.45%
OptionableYes Debt/Eq0.32 EPS Q/Q2.98% Profit Margin-6697.50% Rel Volume0.71 Prev Close0.53
ShortableYes LT Debt/Eq0.30 EarningsNov 14 AMC Payout- Avg Volume303.34K Price0.54
Recom3.00 SMA20-30.60% SMA50-43.86% SMA200-49.15% Volume216,748 Change1.88%
Date Action Analyst Rating Change Price Target Change
Jul-28-23Downgrade Robert W. Baird Outperform → Neutral $9 → $1.50
Feb-22-22Reiterated BTIG Research Neutral $35 → $29
Feb-22-22Downgrade RBC Capital Mkts Outperform → Sector Perform
Feb-22-22Downgrade Oppenheimer Outperform → Perform
Mar-02-21Initiated Stifel Hold $14
Dec-14-20Resumed H.C. Wainwright Buy $30
Aug-11-20Reiterated H.C. Wainwright Buy $37 → $30
Jun-25-20Resumed BofA/Merrill Buy $30
May-13-20Initiated RBC Capital Mkts Outperform $30
Mar-16-20Upgrade Oppenheimer Perform → Outperform $32
Nov-17-23 06:40AM
Nov-16-23 12:18PM
Nov-14-23 05:02PM
04:20PM Loading…
Aug-14-23 04:20PM
Jul-27-23 04:05PM
Jul-06-23 11:17AM
May-16-23 08:00AM
May-11-23 05:35PM
May-03-23 07:30AM
05:52AM Loading…
Mar-27-23 05:52AM
Mar-15-23 04:01PM
Mar-09-23 06:45PM
Mar-02-23 07:30AM
Feb-24-23 05:31AM
Feb-22-23 04:01PM
Jan-05-23 09:25AM
Jan-04-23 04:01PM
Nov-12-22 08:08AM
Nov-10-22 05:45PM
Oct-27-22 09:00AM
Oct-06-22 08:30AM
08:15AM Loading…
Sep-27-22 08:15AM
Sep-08-22 11:05AM
Sep-06-22 04:01PM
Aug-17-22 01:05PM
Aug-16-22 11:52AM
Aug-15-22 06:15PM
Aug-12-22 07:46AM
Aug-11-22 04:05PM
Jul-25-22 09:12AM
Jul-05-22 08:30AM
Jun-29-22 08:00AM
Jun-13-22 08:00AM
Jun-10-22 08:30AM
May-18-22 06:00AM
May-16-22 06:05PM
May-13-22 08:45AM
May-02-22 04:56PM
Apr-21-22 08:30AM
Mar-23-22 05:45PM
Mar-10-22 04:01PM
Mar-08-22 10:00AM
Mar-07-22 09:38AM
Mar-03-22 03:00PM
Feb-24-22 08:45AM
Feb-23-22 10:00AM
Feb-22-22 07:34AM
Feb-21-22 09:40AM
Feb-18-22 04:05PM
Feb-10-22 11:40AM
Feb-02-22 09:40AM
Jan-28-22 10:46AM
Jan-21-22 09:38AM
Dec-12-21 08:19AM
Dec-10-21 06:38PM
Nov-15-21 07:10AM
Nov-03-21 08:29AM
Nov-01-21 03:01PM
Oct-21-21 07:00AM
Oct-20-21 08:30AM
Oct-18-21 08:30AM
Oct-13-21 08:21AM
Oct-12-21 04:05PM
Oct-11-21 08:39AM
Aug-14-21 03:27AM
Aug-12-21 07:05PM
Aug-05-21 08:30AM
Aug-04-21 08:30AM
Aug-02-21 03:01PM
Jun-19-21 05:23AM
May-13-21 07:00AM
May-06-21 06:15PM
May-03-21 08:00AM
Apr-29-21 05:06PM
Apr-28-21 08:00AM
Apr-20-21 03:28AM
Apr-14-21 08:30AM
Apr-12-21 08:30AM
Apr-07-21 12:15PM
Apr-06-21 04:19PM
Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Seymour AlbertSee RemarksSep 06Sale1.151,4481,665150,874Sep 08 04:44 PM
Jordan JulieChief Medical OfficerAug 03Option Exercise0.006,57908,804Aug 07 09:39 PM
Jordan JulieChief Medical OfficerAug 03Sale1.391,8532,5763,882Aug 07 09:39 PM
Jordan JulieChief Medical OfficerAug 02Option Exercise0.0035002,869Aug 04 04:08 PM
Jordan JulieChief Medical OfficerAug 02Sale1.31991302,770Aug 04 04:08 PM
Alloway PaulSee RemarksMar 02Sale1.4510,96515,86316,706Mar 06 04:05 PM
TZIANABOS ARTHURDirectorJan 09Sale1.3910,61614,762108,395Jan 11 04:05 PM
Smith W BradfordSee RemarksJan 09Sale1.393,7295,18814,219Jan 11 04:05 PM
Seymour AlbertSee RemarksJan 09Sale1.393,6205,033143,166Jan 11 04:05 PM
Alloway PaulSee RemarksJan 09Sale1.393,0904,29620,103Jan 11 04:05 PM
Blum Michael LeeChief Commercial OfficerJan 09Sale1.392,4543,41213,538Jan 11 04:05 PM